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Abstract
Introduction: The presence of the HLA-B*27 allele is a major risk factor for the development of ankylosing spondylitis
(AS), which causes chronic inflammation of the spine and other sites. We investigated residual effects outside HLA-B
within the major histocompatibility complex (MHC) region in the Korean population.
Methods: Using the Korean HLA reference panel, we inferred the classic HLA alleles and amino-acid residues of the six
HLA genes (HLA-A, -B, -C,-DPB1, -DQB1, and -DRB1) and MHC single-nucleotide polymorphisms in 3820 Korean subjects,
including 654 Korean cases of AS and 3166 controls, who were genotyped by using Immunochip. Logistic regression
and log-likelihood ratio tests were used in AS association tests for imputed markers.
Results: The most significant associations were identified at amino-acid positions in the epitope-binding site of HLA-B
(P = 1.71 × 10−481 at position 70, P = 7.20 × 10−479 at position 97, and P = 2.54 × 10−484 at positions 114), highlighting
the risk effect of the HLA-B*27 allele and the protective effects of other classic alleles. A secondary effect was located at
the leucine at amino-acid position 116 in the epitope-binding site of HLA-C (P = 1.69 × 10−14), completely tagging the
HLA-C*15:02 allele. This residue had a large effect in HLA-B*27-negative patients (odds ratio = 6.6, 95 % confidence
interval = 3.8 to 11.4).
Conclusions: The four amino-acid positions of HLA-B and -C account for most of the associations between AS and
MHC in the Korean population. This finding updates the list of AS susceptibility loci and provides new insight into AS
pathogenesis mediated by MHC class I molecules.
Introduction
Ankylosing spondylitis (AS) is a highly heritable rheum-
atic disease causing chronic inflammation of axial spine,
joints, and various organs. The presence of HLA-B*27 is
strongly associated with the development of AS, al-
though the underlying mechanism remains unclear [1].
The HLA-B*27 allele is found in approximately 90 % of
patients [1], possibly explaining most of the genetic asso-
ciations between AS and the major histocompatibility
complex (MHC) locus on human chromosome 6.
Some evidence of multiple independent effects within
the MHC locus had been suggested by association
analysis using single-nucleotide polymorphisms (SNPs)
or classic two- or four-digit alleles of human leukocyte
antigen (HLA) genes [1–4]. Recently, our understanding
of the AS-MHC association was further extended by
Cortes et al., who reported a fine-mapping study asses-
sing for the first time the AS associations of SNP, HLA
amino-acid residues, and HLA classic alleles simultan-
eously in European populations [5]. The strongest asso-
ciation was observed for HLA-B amino-acid position 97
in the epitope-binding groove. There were six possible
amino-acid residues at the position and their relative
disease effects widely varied (Asn >> > Thr > Arg ≈ Tyr >
Ser > Val), which explained the known association of
HLA-B*27 and other HLA-B alleles based on the six
amino-acid residues (HLA-B*27 > >HLA-B*51 >… >
HLA-B*07 and HLA-B*08 >HLA-B*57) [5]. In addition,
a novel association passing the genome-wide significance
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threshold was identified at an HLA-A allele after con-
trolling for the effect of HLA-B susceptibility alleles [5].
Here, we conducted a similar fine-mapping study for
the AS-MHC association by using both SNP and HLA
variants (classic alleles and amino-acid residues) in Ko-
rean subjects to investigate the difference of secondary
effects between the Asian and European populations and
to identify novel functional variants conferring risk of
AS in addition to HLA-B*27 in the Asian population.
Methods
Subjects and SNP data
In total, 3820 unrelated Korean subjects comprising 654
cases of AS and 3166 controls were analyzed in this
study. The patients with AS satisfied the modified New
York criteria for AS diagnosis [6]. The study was ap-
proved by the institutional review board of Hanyang
University Hospital for Rheumatic Diseases in Seoul,
Korea. Written informed consent was obtained from
each subject.
The customized SNP array (Immunochip) was used to
obtain high-density SNP data for the extended MHC re-
gion in the study subjects. The Immunochip data were
previously described in our recent studies [2, 7]. By
standard quality-control procedures, SNPs with a minor
allele frequency of at least 0.01, call rates of at least 0.95,
and P values in Hardy-Weinberg disequilibrium tests of
at least 5 × 10−7 in unrelated individuals with SNP call
rates of at least 0.90 were analyzed in this study. The
study subjects were ethnically homogeneous and showed
no evidence of systemic bias or potential population
substructure.
HLA imputation and association analysis
Using the SNP2HLA script [8] and the Korean HLA ref-
erence panel [9], we imputed the two- and four-digit
classic alleles and amino-acid residues of HLA-A, -B, -C,
-DRB1, -DPB1, and -DQB1 as well as MHC SNPs (span-
ning 25–35 Mb on chromosome 6 which this study
aimed to examine variants within). The imputation pro-
vided genotype information of each classic HLA allele,
HLA amino-acid residue, and SNP as a binary variable
[8]. AS associations of all markers with a minor allele
frequency of at least 1 % and imputation quality (PLINK
INFO) of at least 0.8 were assessed by using logistic re-
gression, adding the top 10 principal components as co-
variates. EIGENSTRAT software was used to calculate
the principal components from linkage disequilibrium-
pruned Immunochip-wide genotyped data for non-AS-
associated loci. The known AS loci have been defined in
a large AS Immunochip study [2]. AS associations at
HLA amino-acid positions (or multiple markers) were
assessed by using log-likelihood ratio tests (LRTs)
comparing fits between null and full logistic regression
models. The null model included the 10 principal com-
ponents only; the full model also included dosage of
amino-acid residues at the tested amino-acid position,
excluding the most frequent residue to avoid colinearity
among the residues. Conditional analyses were per-
formed by adding the identified markers as covariates in
logistic regression. HLA-B amino-acid haplotypes were
extracted from long-range haplotypes in the imputed
data. Haplotype-specific odds ratios (ORs) of developing
AS for each haplotype were calculated by using logistic
regression adjusting for the 10 principal components.
Results
Imputing variants in MHC
To dissect the associations between various MHC variants
and AS, we analyzed high-density SNP data from 654
Korean cases of AS and 3166 controls. We imputed 4914
polymorphic variations, including 151 classic alleles and
656 amino-acid variants in HLA-A, -B, -C, -DRB1, -DPB1,
and -DQB1 as well as 4107 MHC SNPs on the basis of
our ethnicity-matched HLA reference panel, which has
been well validated to generate reliable imputation results
from Korean genotype data [9–11].
Consistent with previous AS association studies, a
high frequency of imputed HLA-B*27 allele carriers was
observed in the AS cases (88.1 %) but not in the con-
trols (4.5 %). The imputation-based carrier frequency in
controls was similar to the genotyping-based frequency
in a separate set of Korean subjects (n = 413) in our pre-
vious study (5.1 %) [9]. We note that the Korean HLA
reference panel was reported to yield concordance rates
of 93.4 % for two-digit alleles and 89.3 % for four-digit
alleles of HLA-B between imputed and actual data in
East Asians [9]. Using our study subjects, we observed
an imputation accuracy of 97.4 % for the imputed HLA-
B*27 carriage in 583 AS cases who were conventionally
genotyped for HLA-B*27 carriage as previously
described [12].
AS associations at HLA-B amino-acid positions 70, 97,
and 114
By simultaneously analyzing the associations for the
three types of variant (SNPs, HLA amino-acid residues,
and classic HLA alleles), we identified the most signifi-
cant associations to be at HLA-B amino-acid positions
70, 97, and 114, and significance levels were highly reli-
able (PLRT = 1.71 × 10
−481 at 70, PLRT = 7.20 × 10
−479 at
97, and PLRT = 2.54 × 10
−484 at 114) and in fact stronger
than those of any SNPs or classic HLA alleles, including
HLA-B*27 (P = 2.11 × 10−243; Table 1 and Fig. 1a).
We then attempted to statistically distinguish which
position is driving AS among the three positions (1) by
conditioning the dosage of all residues, excluding the
most frequent allele, at each position for the others and
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(2) by measuring the Akaike information criterion (AIC)
and log-likelihood ratio among logistic models, including
single, two, or three amino-acid positions. We observed
dramatic drops in all P values for various combinations
of amino-acid positions in the cross-conditional analysis
adjusting for each of the three amino-acid positions
(Table 1). In addition, we found similar AIC and PLRT
values for possible amino-acid models (Table 1) so that
we could not statistically pinpoint certain positions
among the three positions. Instead, these results strongly
suggested that the haplotypes defined from the three
positions could be highly stable. The three amino-acid
positions are located in the epitope-binding pocket of
HLA-B (Fig. 1c).
Considering strong linkage disequilibrium in HLA and
uncertainty in imputation, we built an AS and HLA-B
association model by using positions 70, 97, and 114 in a
subsequent analysis. HLA-B amino-acid positions 70, 97,
and 114 can be occupied by four, five, and three com-
mon amino-acid residues, respectively, and each residue
had a distinct effect size (Additional file 1: Table S1). In
total, 11 common amino-acid haplotypes (>1 % among
the subjects) were defined by the three positions in this
Korean study population. Haplotype association analysis
showed that a single haplotype including lysine at 70, as-
paragine at 97, and histidine at 114 was significantly as-
sociated with increased susceptibility to AS (OR = 243.0;
P = 2.70 × 10−216; Table 2), corresponding to HLA-B*27
alleles. Two HLA-B*27 alleles (HLA-B*27:04 and HLA-
B*27:05) were observed in the Korean subjects in this
study. In addition, the haplotype model explains how
other haplotypes confer protection against AS. For ex-
ample, the haplotype including asparagine at 70,
tryptophan at 97, and asparagine at 114 indicated as
HLA-B*14:01 had a highly protective effect (OR = 0.27;
P = 4.34 × 10−3; Table 2).
We note that the AS association of HLA-B in European
populations was explained by HLA-B amino-acid position
97 alone [5]. As compared with the most frequent residue,
arginine, the effect size of asparagine residue (correspond-
ing to HLA-B*27) was larger in the Korean population
(OR = 38.8, 95 % CI = 31.5–47.7) than the European popu-
lation (OR = 16.5, 95 % CI = 15.4–17.7) and serine showed
opposite effects between the populations (OR = 1.28 in
Koreans and OR = 0.86 in Europeans; PCochrane-Q test =
6.93 × 10−4) (Additional file 1: Table S2). It might mean
that serine has a different effect on AS in different popula-
tions. Alternatively, the observed genetic heterogeneity of
the serine residue between the Korean and European an-
cestries can be shown because of the presence of inde-
pendent effects at HLA-B amino-acid position 70 or 114
or may indicate different secondary effects within the
MHC region between the populations that can influence
residue effects at position 97.
AS associations at HLA-C amino-acid position 116
To identify independent genetic effects in addition to
the HLA-B effects, we used a conditional logistic regres-
sion adding the three amino-acid positions 70, 97, and
114 (that is, the dosage of all residues at each position,
excluding the most frequent allele) as covariates to re-
move their primary association effects. A secondary in-
dependent effect was identified at the leucine residue at
HLA-C amino-acid position 116 located in the epitope-
binding groove of HLA-C (P = 1.69 × 10−14; Fig. 1b and d).
We note that the leucine residue was still most strongly
Table 1 Association of HLA-B amino-acid positions 70, 97, and 114 with susceptibility to ankylosing spondylitis
HLA-B association models Null* 1 2 3 4 5 6 7
Amino-acid positions - 70 97 114 70 + 97 97 + 114 70 + 114 70 + 97 + 114
AIC values 3503.0 1285.6 1282.7 1276.2 1282.5 1270 1280.1 1271.6
Log-likelihood test (LRT)
P values in LRT (Ref = Null) Ref 1.71 × 10−481 7.20 × 10−479 2.54 × 10−484 1.91 × 10−477 6.48 × 10−480 2.62 × 10−480 1.12 × 10−478
P values in LRT (Ref = model 1) NA Ref NA NA 0.023 NA 8.75 × 10−3 2.25 × 10−4
P values in LRT (Ref = model 2) NA NA Ref NA 0.10 2.44 × 10−4 NA 7.91 × 10−4
P values in LRT (Ref = model 3) NA NA NA Ref NA 6.35 × 10−3 0.55 8.29 × 10−3
P values in LRT (Ref = model 4) NA NA NA NA Ref NA NA 5.92 × 10−4
P values in LRT (Ref = model 5) NA NA NA NA NA Ref NA 0.22
P values in LRT (Ref = model 6) NA NA NA NA NA NA Ref 2.42 × 10−3
P values for conditioned amino-acid effects
adjusted for position 70 NA NA 0.1028 0.5455 NA 0.2195 NA NA
adjusted for position 97 NA 0.023 NA 6.35 × 10−3 NA NA 2.42 × 10−3 NA
adjusted for position 114 NA 8.75 × 10−3 2.44 × 10−4 NA 5.92 × 10−4 NA NA NA
HLA human leukocyte antigen, AIC Akaike information criterion, Ref reference model, NA not available
* The null model included the 10 principal components only
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associated with AS when adjusted for all four-digit HLA-B
alleles (P = 1.21 × 10−12).
This residue was almost completely correlated with HLA-
C*15:02 (dosage correlation r2 = 1.00, conditioned association
P= 1.79 × 10−14) and enriched in AS patients without the
HLA-B*27 allele (24.4 %), in contrast to AS patients carrying
the allele (2.6 %) and the control group (4.3 %). As expected,
the residue increased AS susceptibility in comparison with
controls and HLA-B*27-negative cases (OR = 6.58, 95 %
CI = 3.80–11.37; P = 1.52 × 10−11). This raises the possi-
bility that another MHC class I molecule, HLA-C, has a
complementary role in AS pathogenesis when the patho-
genic HLA-B*27 molecules are absent.
We combined effects at the four amino-acid positions
in HLA-B and -C into a single disease model. AS sus-
ceptibility was well explained by this model (PLRT =
1.54 × 10−487), indeed significantly better than by the
HLA-B amino-acid model (PLRT = 1.12 × 10
−478).
No evidence of associations at HLA-A in Koreans
After conditioning on the four AS-associated amino-acid
positions, we could not find any HLA variants associated
Fig. 1 Association plots for the extended major histocompatibility complex region. Significance levels of each marker (single-nucleotide polymorphisms,
classic HLA alleles, and HLA amino-acid residues) and amino-acid positions were calculated by using logistic regression and log-likelihood tests, respectively,
and plotted according to chromosomal locations (based on hg18). a Primary association was identified at HLA-B amino-acid positions 70, 97, and 114 in
an unconditional analysis. b Secondary association was identified at HLA-C amino-acid position 116 when conditioned on the primary effect
at the three HLA-B amino-acid positions. c, d Amino-acid positions 70 (yellow), 97 (red), and 114 (green) of HLA-B and 116 of HLA-C (blue) are
located in epitope-binding sites. HLA human leukocyte antigen
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with AS susceptibility (P > 1.19 × 10−5), passing the
genome-wide significance threshold (P = 5 × 10−8). Out-
side of HLA genes, one MHC SNP rs11757571 on three
prime untranslated region (3′-UTR) of HCP5 showed a
significant association (OR = 6.52; P = 2.78 × 10−8; INFO
value = 0.99) but this association needs to be validated in
an independent study because the significance was oddly
depending on conditioning for HLA-B amino-acid pos-
ition 70 among the three correlated HLA-B positions
70, 97, and 114 (after excluding HLA-B amino-acid
position 70 from the covariates, OR = 2.42 and P for
rs11757571 = 3.39 × 10−5).
Cortes et al. [5] have demonstrated a secondary as-
sociation effect, exceeding the genome-wide signifi-
cance threshold, at three correlated HLA-A markers
(e.g., HLA-A*02:01; OR = 1.25 and P = 1.41 × 10−9)
after controlling for the association of HLA-B alleles.
This association was not detected in the Korean popu-
lation but a similar conditioned effect was observed
after adjusting for HLA-B*27 (OR = 1.25; P = 0.08), in-
dicating possible sharing of risk alleles between European
and Koreans. Alternatively, it is also possible that the
sources of secondary effects could differ between Asian
and Europeans. In our analysis, we found an HLA-C
amino-acid variant with a second effect, but the uncondi-
tioned effect of HLA-A*02:01 (OR = 2.63; P = 2.12 × 10−39)
was diminished after conditioning on HLA-B alleles
(OR = 1.10; P = 0.47) or conditioning on HLA-B amino-
acid positions 70, 97, and 114 (OR = 1.12; P = 0.43).
Discussion
Adding HLA amino-acid variants and classic alleles in a
fine-mapping study is very important for better localization
of association effects to precise variants because the identi-
fication of primary and secondary effects highly depends on
adjusting factors used in a conditional analysis. Our results
illustrate the usefulness of adding HLA variants to an MHC
fine-mapping analysis. Consistent with other studies that
have investigated the trait associations down to the amino-
acid level since early 2010 [13, 14], the independent
disease-risk effects were identified at HLA amino-acid posi-
tions, providing a parsimonious and biologically relevant
model.
We used the HLA imputation method and the Korean
HLA reference panel with several types of genetic vari-
ant, including SNPs, two-digit HLA alleles, four-digit
HLA alleles, and HLA amino-acid residues, to localize
AS associations in the extended MHC region. The large
effects were mapped primarily to HLA-B amino-acid po-
sitions 70, 97, and 114. They seemed partially linked
with each other, and the three positions better explained
the association of the established AS-risk HLA-B*27 al-
lele and other protective alleles.
In addition, our findings revealed a novel pathogenic
effect of HLA-C molecules, which can be exerted by leu-
cine at amino-acid position 116 in the middle of the
epitope-binding site. This residue was correlated with
one of the HLA-C*15 alleles that have been suggested to
be associated with Kawasaki disease, Behçet’s disease,
and leprosy [15–17]. However, because this study had
no replication cohort and previous European studies
have not reported the association for HLA-C amino-acid
position 116, this association needs to be validated in an
independent cohort in the future.
We also demonstrate the difference of effect estimates
at HLA-B amino-acid position 97 between populations
Table 2 Association of HLA-B amino-acid haplotype with susceptibility to ankylosing spondylitis
Amino-acid haplotype Haplotype frequency Association for AS
70 97 114 Cases Controls OR (95 % CI) P value
Lys Asn His 0.482 0.025 243.0 (172.4–342.4) 2.70 × 10−216
Asn Ser Asn 0.064 0.087 0.72 (0.56–0.91) 6.38 × 10−3
Gln Ser Asp 0.024 0.038 0.65 (0.45–0.95) 2.55 × 10−2
Asn Arg Asn 0.064 0.103 0.59 (0.47–0.75) 1.49 × 10−5
Gln Thr Asn 0.042 0.069 0.58 (0.44–0.78) 2.77 × 10−4
Gln Arg Asp 0.024 0.044 0.54 (0.37–0.79) 1.24 × 10−3
Asn Thr Asn 0.121 0.217 0.48 (0.40–0.58) 2.02 × 10−15
Ser Arg Asp 0.031 0.065 0.46 (0.33–0.64) 3.70 × 10−6
Asn Arg Asp 0.141 0.319 0.35 (0.30–0.42) 2.74 × 10−34
Asn Trp Asn 0.004 0.014 0.27 (0.11–0.66) 4.34 × 10−3
Asn Ser Asp 0.001 0.012 0.06 (0.01–0.44) 5.69 × 10−3
HLA human leukocyte antigen, AS ankylosing spondylitis, OR odds ratio, CI confidence interval
*Each of the HLA-B classic alleles observed in the Korean subjects belongs to one of the amino-acid haplotypes. Lys-Asn-His: *27:04, *27:05; Asn-Ser-Asn: *08:01,
*40:02, *48:01; Gln-Ser-Asp: *07:02; Asn-Arg-Asn: *13:01, *37:01, *38:02, *39:01, *40:01, *51:06; Gln-Thr-Asn: *54:01, *55:01, *55:02, *56:01, *56:05; Gln-Arg-Asp:
*46:01; Asn-Thr-Asn: *13:02, *40:06, *51:01, *51:02, *52:01, *59:01; Ser-Arg-Asp: *58:01; Asn-Arg-Asp: *15:01, *15:02, *15:11, *15:18, *15:27, *15:38, *18:01, *35:01,
*35:03, *44:02, *44:03; Asn-Trp-Asn: *14:01; Asn-Ser-Asp: *15:07, *40:03
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and a possible difference of secondary association effects
between Asian and European populations. Although
both Korean and European populations have an inde-
pendent disease effect at MHC class I molecules in
addition to HLA-B, the association was mapped at HLA-
A in Europeans but HLA-C in Koreans [5]. The relatively
small size of the Korean subjects may cause the absence
of the HLA-A association because of low statistical
power to detect the effect size (OR = 1.25) observed in
the European cohort (power = 80 % at the significance
level of 0.05 or approximately 0 % at the significance
level of 5 × 10−8 with the fixed allele frequency of 0.184
and the fixed disease prevalence of 0.5 %). Trans-
ancestral association mapping could be useful in obtain-
ing a robust profile of heterogenic associations resulting
from ancestral differences.
Conclusions
In summary, we identified associations of HLA-C in
addition to HLA-B with AS susceptibility in the Korean
population. This updates the list of AS susceptibility loci
and provides new insight into AS pathogenesis mediated
by MHC class I molecules.
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